• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE CARDIOFORM ASD OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE CARDIOFORM ASD OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number ASD37A
Device Problems Inadequacy of Device Shape and/or Size (1583); Migration (4003)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/04/2021
Event Type  Injury  
Event Description
It was reported the physician selected a 37mm gore® cardioform asd occluder to treat an atrial septal defect balloon sized to 17mm in a patient with a deficient retro-aortic rim, measuring 2.3mm.The device was placed without issue; however, after the device was released, a residual shunt was noted.The physician used a 20fr.Dryseal sheath and a snare to attempt device retrieval.During retrieval, the occluder could not be brought into the sheath and embolized to the tricuspid valve.Additional attempts to snare the device from both the groin access and the internal jugular were unsuccessful and the patient was sent directly to surgery for device removal.The patient was doing well following surgery.
 
Manufacturer Narrative
Only the occluder was returned to gore for analysis.The investigation revealed that the occluder was locked with the lock loop through all three eyelets.The size and shape of the occluder and lock loop were unremarkable.The cause of the residual shunt, difficulty retrieving the occluder, and embolization are unknown and cannot be determined from the evidence available.Echocardiography images were returned to for evaluation.The defect appears to be balloon sized appropriately.The rims of the defect superiorly, posteriorly and inferiorly look sufficient enough to support the device implanted.When deploying the device it appears that the anterior portion of the left disc did not wrap around the aorta and slipped through onto the right side of the septum.There also appears to be a small residual shunt coming around the device anteriorly; however, the device is very deformed from the tension of delivery system.It is unclear from the imaging provided if this resolved before the locking loop was released.The device is then visualized much flatter on the septum.This appearance is consistent with the locking loop being released and tension from the delivery system removed.It is unclear from the imaging when the retrieval suture was removed.The device appears to have captured the posterior, superior and inferior tissue successfully; however, the anterior portion of the left disc appears to have slipped through the defect.With the left anterior disc not wrapped around the aorta and on the right side of the septum a clear residual shunt by the aorta is visualized.The gore® cardioform asd occluder instructions for use (ifu) list device embolization as a potential clinical and device adverse event.Additionally, the ifu also advises removal of the device if the selected occluder will not come to rest in a planar position apposing the septal tissue or allows excessive shunting.Code 1583 was incorrectly added as a medical device problem code on the initial report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE CARDIOFORM ASD OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key11584586
MDR Text Key242816566
Report Number2017233-2021-01820
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00733132636501
UDI-Public00733132636501
Combination Product (y/n)N
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 04/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/29/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/21/2023
Device Model NumberASD37A
Device Catalogue NumberASD37A
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer03/15/2021
Date Manufacturer Received03/04/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age16 YR
Patient Weight83
-
-